We’re investigating what biopharma professionals wish companies would do differently when they lay off employees. If you’ve been laid off and want to share your thoughts on what employers do that makes a tough situation worse, please email Angela Gabriel at angela.gabriel@biospace.com or message her here on LinkedIn.
BioSpace
Internet News
West Des Moines, Iowa 127,895 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis
Market Intelligence Advisor | Moderator | Professional Speaker
-
Heather McKenzie
Senior Editor at BioSpace
Updates
-
Following Regeneron's acquisition of U.K.-based Oxular, an undetermined number of Oxular employees are losing their jobs. Get the details on this workforce reduction in our layoff tracker. #layoffs #biopharma #biospace https://hubs.ly/Q0315qWc0
-
Novo Nordisk's GLP-1s outsell Eli Lilly and Company's thanks to its superior marketing. Here’s how. #GLP1 #obesity #biospace https://hubs.li/Q0314wQ90
Opinion: Why Is Novo Outperforming Lilly Despite Having Inferior GLP-1 Products?
biospace.com
-
Eli Lilly and Company's request to intervene in a suit filed by compounding pharmacies against the FDA reflects a belief the outcome could affect its business and that the FDA does not adequately represent its interests. #FDA #lawsuit #GLP1 #biospace https://hubs.li/Q0313Nnn0
Lilly Asks to Join GLP-1 Compounding Lawsuit
biospace.com
-
Job postings in California took a dip in December during the holiday period, but activity is expected to pick up in January. Companies including Amgen, Gilead Sciences and Eli Lilly and Company are hiring. #jobs #biopharma #biospace https://hubs.li/Q030-1fV0
7 Companies Hiring in California
biospace.com
-
As market values increase for computational biology and data science, biopharma companies are looking to hire R&D professionals in those areas. Conor Sullivan, a biotech talent acquisition expert at Harbinger Health, shares his insights on these in-demand roles. #jobs #biopharma #biospace https://hubs.li/Q030-mYG0
Computational Biology, Data Science Hot Areas for Oncology R&D Hiring
biospace.com
-
With two earlier trials meeting their primary endpoints, Axsome Therapeutics, Inc. claimed it has the data to support a filing for FDA approval in the second half of 2025. #alzheimers #pharma #biospace https://hubs.li/Q030ZWsL0
Axsome Posts Mixed Phase III Data in Alzheimer’s Agitation, Plans FDA Filing
biospace.com
-
Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks. #pharma #biospace https://hubs.li/Q030ZqzK0
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
biospace.com
-
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh discuss the industry’s need to catch up with women’s health issues and the innovative lead the APAC region has taken in clinical trials. #podcast #clinicaltrial #biospace https://hubs.li/Q030ZVZX0
Trials and Capital: Women’s Health and APAC's Healthcare Revolution
biospace.com
-
Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck's Winrevair and the FDA’s greenlight for an injectable formulation of Bristol Myers Squibb's cancer blockbuster. #FDA #drugapprovals #pharma #biospace https://hubs.li/Q030ZpTT0
2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US
biospace.com